Your browser doesn't support javascript.
loading
Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study.
Hundemer, Gregory L; Agharazii, Mohsen; Madore, François; Vaidya, Anand; Brown, Jenifer M; Leung, Alexander A; Kline, Gregory A; Larose, Eric; Piché, Marie-Eve; Crean, Andrew M; Shaw, Julie L V; Ramsay, Tim; Hametner, Bernhard; Wassertheurer, Siegfried; Sood, Manish M; Hiremath, Swapnil; Ruzicka, Marcel; Goupil, Rémi.
Afiliación
  • Hundemer GL; Department of Medicine, Division of Nephrology, University of Ottawa, Ontario, Canada (G.L.H., M.M.S., S.H., M.R.).
  • Agharazii M; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ontario, Canada (G.L.H., T.R., M.M.S., S.H., M.R.).
  • Madore F; Department of Medicine, Division of Nephrology, CHU de Québec-Université Laval, Quebec City, Canada (M.A.).
  • Vaidya A; Department of Medicine, Division of Nephrology, Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Quebec, Canada (F.M., R.G.).
  • Brown JM; Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension (A.V.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Leung AA; Division of Cardiovascular Medicine (J.M.B.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Kline GA; Department of Medicine, Division of Endocrinology and Metabolism (A.A.L., G.A.K.), Cumming School of Medicine, University of Calgary, Alberta, Canada.
  • Larose E; Department of Community Health Sciences (A.A.L.), Cumming School of Medicine, University of Calgary, Alberta, Canada.
  • Piché ME; Department of Medicine, Division of Endocrinology and Metabolism (A.A.L., G.A.K.), Cumming School of Medicine, University of Calgary, Alberta, Canada.
  • Crean AM; Department of Medicine, Division of Cardiology, Université Laval, Quebec City, Canada (E.L., M.-E.P.).
  • Shaw JLV; Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Quebec City, Canada (E.L., M.-E.P.).
  • Ramsay T; Division of Cardiovascular Medicine, Ottawa Heart Institute, Ontario, Canada (A.M.C.).
  • Hametner B; Department of Pathology and Laboratory Medicine, Division of Biochemistry, Ottawa Hospital, Ontario, Canada (J.L.V.S.).
  • Wassertheurer S; Eastern Ontario Regional Laboratories Association, Ottawa, Canada (J.L.V.S.).
  • Sood MM; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ontario, Canada (G.L.H., T.R., M.M.S., S.H., M.R.).
  • Hiremath S; Center for Health & Bioresources, AIT Austrian Institute of Technology, Vienna, Austria (B.H., S.W.).
  • Ruzicka M; Center for Health & Bioresources, AIT Austrian Institute of Technology, Vienna, Austria (B.H., S.W.).
  • Goupil R; Department of Medicine, Division of Nephrology, University of Ottawa, Ontario, Canada (G.L.H., M.M.S., S.H., M.R.).
Circulation ; 149(2): 124-134, 2024 01 09.
Article en En | MEDLINE | ID: mdl-38031887
ABSTRACT

BACKGROUND:

Primary aldosteronism, characterized by overt renin-independent aldosterone production, is a common but underrecognized form of hypertension and cardiovascular disease. Growing evidence suggests that milder and subclinical forms of primary aldosteronism are highly prevalent, yet their contribution to cardiovascular disease is not well characterized.

METHODS:

This prospective study included 1284 participants between the ages of 40 and 69 years from the randomly sampled population-based CARTaGENE cohort (Québec, Canada). Regression models were used to analyze associations of aldosterone, renin, and the aldosterone-to-renin ratio with the following measures of cardiovascular health arterial stiffness, assessed by central blood pressure (BP) and pulse wave velocity; adverse cardiac remodeling, captured by cardiac magnetic resonance imaging, including indexed maximum left atrial volume, left ventricular mass index, left ventricular remodeling index, and left ventricular hypertrophy; and incident hypertension.

RESULTS:

The mean (SD) age of participants was 54 (8) years and 51% were men. The mean (SD) systolic and diastolic BP were 123 (15) and 72 (10) mm Hg, respectively. At baseline, 736 participants (57%) had normal BP and 548 (43%) had hypertension. Higher aldosterone-to-renin ratio, indicative of renin-independent aldosteronism (ie, subclinical primary aldosteronism), was associated with increased arterial stiffness, including increased central BP and pulse wave velocity, along with adverse cardiac remodeling, including increased indexed maximum left atrial volume, left ventricular mass index, and left ventricular remodeling index (all P<0.05). Higher aldosterone-to-renin ratio was also associated with higher odds of left ventricular hypertrophy (odds ratio, 1.32 [95% CI, 1.002-1.73]) and higher odds of developing incident hypertension (odds ratio, 1.29 [95% CI, 1.03-1.62]). All the associations were consistent when assessing participants with normal BP in isolation and were independent of brachial BP.

CONCLUSIONS:

Independent of brachial BP, a biochemical phenotype of subclinical primary aldosteronism is negatively associated with cardiovascular health, including greater arterial stiffness, adverse cardiac remodeling, and incident hypertension.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Hiperaldosteronismo / Hipertensión Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Hiperaldosteronismo / Hipertensión Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Año: 2024 Tipo del documento: Article